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Abstract
The M184V mutation in HIV reverse transcriptase (RT) is associated with high-level resistance against the nucleoside inhibitor
lamivudine as well as diminished viral replication capacity. We have previously demonstrated that HIV variants containing the M184V
mutation were relatively unable to successfully undergo compensatory mutagenesis following deletion of an A-rich loop located upstream
of the primer binding site (PBS). To understand the mechanisms involved, we synthesized viral RNA templates containing different
compensatory mutations that were emergent during the long-term culture of the A-rich loop-deleted viruses. These templates were then used
in cell-free reverse transcription initiation assays and in tRNA primer placement assays performed with either recombinant wild-type RT
or recombinant RT containing the M184V substitution. The results showed that the RNA template that contained the A-rich loop deletion
was impaired in ability to initiate reverse transcription and that the presence of the M184V substitution in RT amplified this effect. Clearance
from pausing at position 3 during synthesis of viral DNA was identified as a sensitive step in this reaction that could not be efficiently
bypassed with the M184V mutant enzyme. Increased efficiency of initiation was seen with the deleted RNA templates that also contained
mutations identified in the revertant viruses, provided that these mutations facilitated formation of a competent binary tRNA/RNA complex.
These findings provide biochemical evidence that initiation of tRNALys3-primed DNA synthesis is an important rate-limiting step in reverse
transcription that correlates with viral replication fitness.
© 2003 Elsevier Science (USA). All rights reserved.
Keywords: Human immunodeficiency virus type 1; Reverse transcriptase; Initiation; tRNALys3; M184V
Introduction
The reverse transcriptase (RT) enzyme of HIV-1 is mul-
tifunctional and possesses each of RNA- and DNA-depen-
dent DNA polymerase (RDDP and DDDP) activities as well
as a ribonuclease H (RNase H) function that degrades tran-
scribed RNA (Gilboa et al., 1979; Telesnitsky and Goff,
1997). Nucleoside analogue RT inhibitors (NRTIs) such as
3-azido-3-dideoxythymidine (AZT) and 2,3-dideoxy-3-
thiacytidine (3TC) that act as chain terminators of nascent
DNA synthesis, as well as nonnucleoside RT inhibitors
(NNRTIs), are used in the treatment of HIV disease (Emini
and Fan, 1997). However, RT is extremely error-prone and
this results in mutations in the viral genome that are asso-
ciated with drug resistance (Bebenek and Kunkel, 1993).
A M184V mutation within the highly conserved (Y183,
M184, D185, D186) amino acid region that includes the
active (catalytic) site of the p66 polymerase domain of RT
(Balzarini, 1999) is unique in its effects on HIV-1 suscep-
tibility to a variety of antiviral agents. The rapid emergence
of the M184V mutation in RT leads to high-level (i.e.,
1000-fold) resistance against lamivudine (3TC) (Boucher
et al., 1993; Gao et al., 1993; Schinazi et al., 1993; Tisdale
et al., 1993) as well as low-level resistance (i.e., 3- to
10-fold) against each of 2,3-dideoxyinosine (ddI), 2, 3-
dideoxycytidine (ddC) (Gao et al., 1993), and abacavir
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(ABC) (Harrigan et al., 2000; Tisdale et al., 1997). In
addition, this mutation confers to HIV each of the follow-
ing: (1) marginally reduced viral fitness and diminished RT
processivity (Back et al., 1996; Boyer and Hughes, 1995;
Sharma and Crumpacker, 1999); (2) a modest increase in
the fidelity of both the DDDP and RDDP activities in
reverse transcription (Feng and Anderson, 1999; Hsu et al.,
1997; Rezende et al., 1998; Wainberg et al., 1996); (3)
diminished ability of viral RT to enact the reverse reaction
of polymerization, i.e., pyrophosphorylysis and/or primer
nucleotide unblocking (Arion et al., 1998; Go¨tte et al., 2000;
Meyer et al., 1998, 1999), (4) hypersensitization to other
nucleoside analogue RT inhibitors (NRTIs) (Miller et al.,
1999; Wainberg et al., 1999; Diallo et al., 2002).
The fact that these distinct, and possibly independent,
effects are associated with the M184V substitution suggests
that this mutation may potentially confer benefit by render-
ing HIV less capable of undergoing rapid replication and, by
inference, of mutating into new forms. Incorporation of
incorrect nucleotides generally occurs more slowly than
accurate polymerization steps, and it appears that the
M184V substitution may amplify this effect. Mutations at
the strategic position of residue 184, located in close prox-
imity to the enzymatic active site, may affect the formation
of competent polymerization complexes that involve bind-
ing of inferior substrates. Both the nature of the incoming
nucleotide triphosphate and the structure of the primer/
template substrate are important parameters in this regard
(Go¨tte et al., 2001; Li et al., 1997).
Cellular tRNALys3 is used as a primer to initiate RT
activity and synthesis of viral DNA (Go¨tte et al., 1999; Mak
and Kleiman, 1997; Marquet et al., 1995). This tRNA
primer is incorporated into the virion during its assembly
and binds via a stretch of 18 nucleotides at its 3 terminus to
a complementary primer binding site (PBS) near the 5 end
of viral RNA (Jiang et al., 1993; Mak et al., 1994). The
initiation of RNA-primed synthesis of minus- and plus-
strand DNA represents a rate-limiting step of reverse tran-
scription. The efficiency of incorporation of both correct
and incorrect nucleotides is reduced with RNA compared
with DNA primers (Go¨tte et al., 2001; Lanchy et al., 1998;
Thrall et al., 1998), and the sequence and structure of the
RNA template in the region of the PBS also play a key role
during initiation (Isel et al., 1995, 1998). We have previ-
ously demonstrated that HIV-1 that is deleted of an A-rich
loop ((169) AAAA (172)), located 10 nucleotides up-
stream of the PBS, is initially impaired but can revert to
near-wild-type replication capacity following compensatory
mutagenesis (Liang et al., 1997). Both our group and others
have also documented that interactions between this A-rich
loop and the anticodon loop of tRNALys3 may be important
for initiation of reverse transcription (Isel et al., 1995, 1998;
Liang et al., 1997; Zhang et al., 1998). Indeed, the compen-
satory mutations that restored viral replication following
deletion of this A-rich region occurred at bases located
immediately upstream of the deleted region; these mutations
also led to partial restoration of this A-rich region. In addi-
tion, HIV-1 is capable of using alternate cellular tRNAs to
initiate reverse transcription, provided that the A-rich loop
has been mutated to a sequence that allows binding to the
alternative anticodon loop (Kang et al., 1997; Wakefield et
al., 1996). However, additional mutations are required to
fully establish the recruitment of other tRNA primers, and
the M184V mutation may compromise the emergence of
second site revertants (Li et al., 1997). Indeed, HIV-1 vari-
ants containing M184V in a background of the A-rich loop
deletion were severely compromised in regard to ability to
regain viral replication competence, despite the fact that
these viruses retained the ability to use the natural tRNALys3
primer. Long-term culture of deletion-containing viruses
that included a wild-type codon at position 184 (184M)
resulted in revertants with mutations at various positions in
close proximity to the deletion, and a T 3 A transversion,
located downstream of the deleted A-rich loop, played an
important role in restoration of viral replication (Wei et al.,
2002).
We now show that use of RNA templates containing
deletions of the A-rich loop compromised the efficiency of
reverse transcription and that the presence of the M184V
mutation in RT amplified this effect. In the absence of
M184V in RT, a T3 A transversion in viral RNA increased
the efficiency of initiation under physiologically relevant
conditions in the presence of the viral nucleocapsid protein
(NCp7) that facilitates the placement of tRNALys3 onto the
PBS. These data suggest that decreased rates of tRNA-
primed initiation of reverse transcription may be correlated
with diminished viral replication fitness.
Results
The A-rich loop and the M184V substitution in RT affect
early steps of reverse transcription in cell-free reactions
performed with synthetic RNA templates and natural
tRNALys.3 primer
We have previously demonstrated that deletion of the
A-rich loop causes diminished viral replication fitness and
that the presence of the M184V substitution in RT further
amplifies this effect (Wei et al., 2002). We now wished to
determine the effects of both the M184V mutation and the
deletion in the A-rich loop on the earliest stages of HIV-1
reverse transcription. To this end, we devised an in vitro
six-nucleotide extension assay to assess events governing
initiation of reverse transcription, in which the chain-termi-
nating nucleotide ddATP was incorporated at position 6
during synthesis of minus-strand, strong stop DNA
(()ssDNA) (Fig. 1A). In terms of overall initiation effi-
ciency, the PBS/A RNA template displayed a measurable
decrease compared with PBS/WT in reactions performed
with either WT RT or M184V (Fig. 1B). A far more drastic
difference in this regard was observed in comparisons be-
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Fig. 1. Effects of the A-rich loop deletion and M184V substitution in RT on initiation of reverse transcription. (A) Graphic representation of the cell-free
six-base extension assay system for study of initiation of reverse transcription. The PBS/WT RNA template employed in this system consists of 258
nucleotides at the 5 end of the HIV-1 genome that contains the R, U5, and PBS regions. The PBS/A template has the same sequences as found in PBS/WT,
except for the deletion of the A-rich loop in the R region, which is highlighted in boldface. (B) Initiation of synthesis of ()ssDNA from each of the PBS/WT
and PBS/A templates using either wild-type RT or M184V mutated RT. Each panel shows a time course of DNA synthesis, monitored by incorporation
of [-32P]dCTP into growing DNA chains. Reactions were terminated after extension of six nucleotides by the incorporation of ddATP. Samples were
analyzed after 1, 2, 4, 6, 8, 10, 12, 15, 20, 30, 45, and 60 min (lanes 1–12). Relative RNA concentrations were determined using Molecular Analyst software.
(C) Log-scale plots of the percentage of the 3 pause product relative to total RNA product at each time point. (D) Relative percentage of the 1 and 3
pause products compared with total RNA product after 60 min.
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tween M184V RT and WT RT, with the M184V RT being
less efficient in each case.
Important features of the initiation reaction are the strong
pausing events that occur at several nt stages. In this regard,
the tRNA-primed reaction was analyzed in time-course ex-
periments to visualize differences in pausing profiles. Re-
actions performed with mutated template (PBS/A) yielded
increased pausing at positions 3 and 5 in comparison to
reactions with wild-type template (PBS/WT) (Fig. 1B).
These differences were further analyzed by comparing the
relative formation of the 3 product, representing com-
plexes that had reached the pausing site at position 3, and
products at positions 5 and 6, representing complexes
that had successfully passed the 3 pausing site, and the
results are summarized in the graph shown in Fig. 1C. It is
clear that the M184V mutant enzyme caused a significant
delay in clearance from pausing, and reactions performed
with this enzyme reached the 3 pause site only at later
time points. Escape from pausing was almost absent when
using the deletion-containing template in these reactions.
When the distribution of products at positions 1, 3, and
5/6 was further analyzed after a 60-min reaction, it was
observed that use of the M184V RT resulted in stronger
pausing at the1-nt stage compared with the use of WT RT
in reactions performed with the PBS/A RNA template
(Fig. 1D). The strong pausing at positions 1 and 3,
associated with the M184V RT, reflects the decreased abil-
ity of the latter enzyme to processively caltalyze reverse
transcription, as has previously been reported (Back et al.,
1996). Diminished viral replication capacity on the part of
viruses containing M148V may result from both the lower
efficiency of the initiation reaction and the diminished pro-
cessivity associated with M184V RT.
Efficiency of initiation of minus-strand DNA synthesis
using mutated RNA templates
Long-term culture of viruses containing the A-rich loop
deletion resulted in the emergence of breakthrough variants
that contained compensatory mutations in the vicinity of the
deletion (Liang et al., 1997; Wei et al., 2002). A revertant
termed HIV-1/R0 had a G3 A substitution at position 167;
two other revertants, i.e., HIV-1/R1 and HIV-1/R2, con-
tained single T 3 A and C 3 A substitutions at positions
173 and 176, respectively; and the revertant HIV-1/R1-2
contained both of the latter mutations (Fig. 2). Among these
revertants, HIV-1/R1 was able to replicate with an effi-
ciency similar to that of wild-type HIV-1 and became dom-
inant in the outgrowth of viruses from the original HIV-
1/A stock. In contrast, viruses containing the M184V
mutation in RT together with the deletion of the A-rich loop
neither reverted nor recovered replication ability over pro-
tracted periods (Wei et al., 2002).
To study mechanisms whereby the various revertants
established partial restoration of replication fitness, we next
analyzed the efficiency of tRNA-primed ()ssDNA synthe-
Fig. 1 (continued)
205X. Wei et al. / Virology 311 (2003) 202–212
sis using in vitro-synthesized RNA templates containing the
corresponding genetic alterations. Consistent with its ad-
verse effects on viral replication, use of the PBS/A tem-
plate led to lower levels of ()ssDNA in the cell-free
reactions compared with use of the WT RNA template (Fig.
3). Unexpectedly, the efficiency of ()ssDNA synthesis
with PBS/R1, i.e., the mutant that showed the highest rep-
lication capacity in tissue culture, remained diminished
(Fig. 3). The efficiency of pausing at position 3 appeared
to be increased, as compared with reactions conducted with
wild-type template PBS/WT. In contrast, PBS/R2, i.e., the
mutant that showed the worst replication capacity, resulted
Fig. 2. RNA template containing the A-rich loop deletion and revertant viral sequences emergent in long-term tissue culture. The A-rich loop sequence and
mutated nucleotides are highlighted in bold. The underlined TGGCG sequence represents the 5 end of the primer-binding site (PBS).
Fig. 3. Synthesis of ()ssDNA from each of the PBS/WT and PBS/A templates as well as RNA templates containing different reversions. Each panel shows
a time course of synthesis of ()ssDNA performed by HIV-1 WT RT. Reactions were initiated by preforming the natural tRNA/RNA complex and were
stopped after 1, 5, 10, 30, and 60 min (lanes 1–5).
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in a significantly increased efficiency of ()ssDNA synthe-
sis, exceeding even that generated with PBS/WT. Similar
results were obtained with the PBS/R0 mutant template, and
both of these cases also resulted in a virtual elimination of
pausing during the initiation stage.
These in vitro data may appear to contradict those from
the in vivo experiments. One possibility is that reverse
transcription, under in vivo conditions, takes place with the
assistance of many cellular and viral proteins. Of the latter,
the viral NC protein is known to play a major role in many
aspects of synthesis of viral cDNA, including the placement
of tRNALys.3 onto the PBS (Li et al., 1996). Indeed, RT
reactions that are initiated with viral RNA-tRNALys3 com-
plexes formed in this way exhibit significantly higher effi-
ciency of processivity than is seen in cell-free assays per-
formed with viral RNA-tRNALys3 complexes that are
formed by heat annealing (Rong et al., 1998). It is conceiv-
able that HIV has evolved in vivo strategies that prevent
pausing during cDNA synthesis.
Thus, to better mimic in vivo conditions, we also ana-
lyzed the efficiency of ()ssDNA synthesis using our var-
ious mutant templates in the presence of NCp7 (Fig. 4A). In
agreement with our previous findings, very few pausing
events were detected in reactions performed with NCp7.
Consistent with results obtained using heat-annealed viral
RNA–tRNALys3 complexes, reactions performed with the
PBS/A mutant template yielded levels of ()ssDNA
lower than those obtained with PBS/WT template (Fig. 4).
Interestingly, the PBS/R1 template generated even higher
levels of ()ssDNA than did PBS/WT, in contrast to the
relatively lower levels of ()ssDNA obtained with either
PBS/R0 or PBS/R2 (Fig. 4). These findings help to explain
the in vivo observation that the PBS/R1 revertant exhibited
the highest replication capacity among the PBS/R0, PBS/
R1, and PBS/R2 viruses.
Reactions performed with the M184V mutation showed
the same patterns, although the efficiency of DNA synthesis
was further diminished in each of these cases. The data of
Fig. 4B confirm these results on the basis of relative levels
of reaction products after 60 min as monitored by gel
scanning. In Fig. 4B, total levels of incorporated radioac-
tivity were compared with reactions performed with both
wild-type template and RT that were arbitrarily assigned a
value of 100%.
Why does the PBS/R1 RNA template perform differently
in reactions carried out with heat-annealed versus NC-an-
nealed viral RNA–tRNALys3 complexes? We have shown
that a strong 3 pause site persists in reactions performed
with the PBS/R1 but not with either the PBS/R0 or PBS/R2
template (Fig. 3). It is important to note that cDNA products
in these reactions are visualized on gels by incorporation of
[-32P]dCTP. The 3 paused cDNA products that are seen
with PBS/R1 are further extended in reactions performed
with NCp7-annealed template than with heat-annealed tem-
plate (compare Fig.3 and 4A). As a consequence, more
[-32P]dCTP is incorporated into ()ssDNA under condi-
tions of NC annealing (Fig. 4). Therefore, although heat-
annealed viral RNA–tRNALys3 complexes can be used to
initiate reverse transcription, a more faithful representation
of ()ssDNA synthesis resulted from the use of NC-an-
nealed primers, regardless of whether WT or mutated tem-
plates were employed.
Data that sumarize the results of viral replication assays
versus synthesis of viral DNA, using either NC-annealed or
heat-annealed primer:template are provided in Table 1. It
should be noted that a general correlation appears to be
present between viral replication capacity and the efficiency
of initiation of reverse transcription for each of the con-
structs employed in RT reactions that used NC-annealed
primer:template complexes. In contrast, no such correlation
was present for reactions performed with heat-annealed
complexes. This again provides evidence for the superiority
of NC annealing over heat annealing in cell-free RT reac-
tions.
Discussion
HIV resistance to the antiviral drug 3TC is attributable to
the M184V amino acid substitution in RT. However, this
mutation is also associated with decreased viral replicative
fitness as well as multiple changes in enzymatic properties
that include diminished processivity of DNA synthesis
(Back et al., 1996; Boyer and Hughes, 1995; Sharma and
Crumpacker, 1999), moderate increases in the fidelity of
polymerization (Feng and Anderson, 1999; Hsu et al., 1997;
Wainberg et al., 1996), and decreased excision of incorpo-
rated AZT and 3TC monophosphates from the primer ter-
minus of newly synthesized viral DNA (Go¨tte et al., 2000).
Previous studies from our laboratory have shown that
deletion of the A-rich loop attenuates HIV with respect to
both viral replication capacity and synthesis of ()ssDNA
(Liang et al, 1997). In addition, we have shown that the
M184V substitution impeded compensatory mutagenesis
when present in viruses that were deleted of the A-rich loop,
which is important for formation of a reverse transcription
initiation complex (Wei et al., 2002). We hypothesized that
M184V might diminish the formation of this complex and
have now studied the mechanisms involved using cell-free
reverse transcription assays.
Earlier studies had shown that the initiation reaction is a
slow process, accompanied by frequent pausing of the RT
enzyme at positions 3 and 5 (Isel et al., 1996; Liang et
al., 1998). Thereafter, a sharp transition occurs to a faster
and more processive mode of polymerization after incorpo-
ration of the sixth nucleotide (Lanchy et al., 1998, 2000;
Thrall et al., 1998). In this article, we have generated mu-
tated RNA templates containing the A-rich loop deletion
and different reversion sequences found in the long-term
culture of mutated viruses. By using a cell-free six-base
extension assay, we found that the M184V mutation re-
duced the rate of tRNA-primed DNA synthesis; notably,
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pausing at position 3 appeared at a later time compared
with reactions performed with wild-type HIV-1 RT. In
regard to the use of RNA templates deleted of the A-rich
loop, we found that the rates of incorporation of the first one
to three nucleotides were not significantly changed in com-
parison to studies performed with wild-type template; how-
ever, the probability of pausing at the 5 position was
significantly increased when the A-rich loop was deleted.
Delayed clearance from both pause sites was seen with both
the mutant enzyme and the mutated RNA template. Clearly,
these alterations result in reduced efficiency of initiation of
synthesis of ()ssDNA. These effects were specific for the
Fig. 4. (A) Cell-free synthesis of ()ssDNA after placement of primer tRNAlys3 onto different RNA templates by NCp7. The tRNA/viral RNA complex was
preformed at 37°C in the presence of NCp7. After incubation of this complex together with wild-type RT or M184V RT at 37°C for 5 min, reactions were
initiated by the addition of dNTPs. Samples were removed after 30 and 60 min (lanes 1, 2). (B) The results depict the relative levels of radioactivity of final
reaction products after 60 min. The amount of radioactivity of the final product of reactions performed with PBS/WT template and WT RT was standardized
as 100%.
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tRNA-primed reaction, since the initiation of reverse tran-
scription was unaffected in reactions performed with a DNA
primer (data not shown). This result supports our hypothesis
that the efficient use of nucleic acid substrates that show
reduced affinity for wild-type RT is further compromised in
the presence of the M184V mutation.
Increased pausing at the 5 position, in the context of
the mutated template, is consistent with the notion that the
interaction between the A-rich loop and the anticodon loop
of tRNALys3 may facilitate the transition from initiation to
elongation after incorporation of the sixth residue (Lanchy
et al., 2000). Deletion of the A-rich loop may have caused
severe structural rearrangements in the binary complex be-
tween viral RNA template and tRNALys3 that resulted in
increased pausing at position 5, which, in turn, caused a
delay in transition to the faster and more processive elon-
gation phase. In contrast to the mutated RNA template, the
M184V mutation may directly affect the interaction with the
tRNA primer, which helps to explain the relatively late
appearance of the pause product at position 3 in reactions
performed with the mutated RT. Together, these data show
that deletion of the A-rich loop and presence of M184V
affect the initiation reaction in a complementary and possi-
bly synergistic fashion, resulting in greater impairment in
synthesis of ()ssDNA than seen with either alteration on
its own.
Enzymatic and mutagenesis assays of the tRNALys3/
RNA complex have revealed the existence of a stem–loop
structure, i.e., the U5-PBS hairpin, in which the A-rich loop
is located in the center of the sequence, (163)GUGUG-
GAAAAUCUCU(177) (Berkhout, 1996; Beerens et al.,
2000b). Mutations that alter the stability of this hairpin
structure and genetic alterations that cause severe structural
changes in RNA template can inhibit virus replication (Bee-
rens and Berkhout, 2000; Beerens et al., 2000a). We have
previously shown that long-term culture of viruses contain-
ing a deletion of the A-rich loop in MT2 cells resulted in the
restoration of one or two As either upstream or downstream
of the deletion. Among the revertants studied, only HIV-1/
R1, which contains a single T3 A replacement at position
173, was able to restore viral replication to nearly wild-
type levels, while another single C 3 A substitution at
position 176 in HIV/R2 resulted in further diminution of
viral replication. Thus, the positions of these various com-
pensatory mutations can differentially impact on viral rep-
lication.
The restoration of the A at 173, located within the loop
of the U5-PBS hairpin, may have helped to restore the
stem–loop structure and hence to increase viral replication.
The fact that position 176 is located within the stem may
mean that restoration of an A at this site is not sufficient to
re-form the loop structure, since, as for the deletion of the
A-rich loop, the destabilization of the hairpin structure may
have resulted in diminished viral replication. Interestingly,
the doubly mutated HIV/R12 did not replicate as efficiently
as either HIV/R1 or HIV/WT, indicating that the mutation at
position 176 may play another structural and possibly
functional role at other stages of viral replication. The ef-
ficiency of placement of the tRNA primer onto the PBS is a
logical factor in this regard.
To address this issue, we also analyzed the efficiency of
tRNA-primed DNA synthesis under physiologically rele-
vant conditions, i.e., at 37°C, in the presence of the viral
NCp7. Previous in vitro studies have shown that the mature
viral nucleocapsid protein NCp7, as well as the Pr55gag
precursor, can promote annealing between tRNALys3 and
PBS (Huang et al., 1997, 1998; Rong et al., 1998). We have
now shown that levels of synthesis of ()ssDNA, generated
in the presence of NCp7, could be correlated with the
efficiency of viral replication. In contrast to results obtained
with heat-annealed complexes, template PBS/R2 generated
less full-length ()ssDNA than any of the other mutated
templates, and the use of PBS/R1 facilitated the formation
of ()ssDNA. These data suggest that the mutation at po-
sition 176 impacted negatively on viral replication at the
placement stage, and that the mutation at position 173
promoted the formation of a competent binary tRNA/RNA
complex.
In summary, the results of this study suggest that the
efficiency of tRNA-primed initiation of reverse transcrip-
tion correlates with the efficiency of viral replication com-
petence. Both placement of tRNALys3 onto the PBS and
rates of initiation of DNA synthesis are important factors
that determine the yield of ()ssDNA. The A-rich loop
Table 1
Effects of various mutations on viral replication and synthesis of viral DNA
Construct Viral replication Synthesis of ()ssDNA (% of wild-type)a
Heat-annealed
Template:primer
NC-annealed
Template:primer
HIV-1/WT Wild type 100 100
HIV-1/A Moderate attenuation 52 38
HIV/R0 Moderate attenuation 112 52
HIV-1/R1-2 Moderate attenuation 118 88
HIV-1/R1 Slight attenuation 68 144
HIV-1/R2 Severe attenuation 154 59
a Results based on gel scanning.
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plays a crucial role in these stages of reverse transcription,
because it is essential for the formation of properly folded
genomic RNA, and changes in viral RNA structure in close
proximity to the PBS can affect tRNA placement and ini-
tiation of DNA synthesis. Synthesis of viral DNA with
either mutated or wild-type templates is a far less efficient
process with mutated M184V-containing than wild-type en-
zyme. We hypothesize that there is a diminished ability on
the part of the mutated enzyme to recognize the initiation
complex of tRNA and viral genomic RNA and further
studies to address this topic are in progress. Furthermore, it
is now of interest to study whether mutant enzymes with
other amino acid substitutions that are likewise associated
with reduced viral replication fitness may give rise to sim-
ilar defects on the level of initiation of DNA synthesis. Such
impaired initiation of synthesis of viral DNA was not ob-
served with other mutated purified RTs, such as those con-
taining substitutions at either position E89G or K65R (re-
sults not shown).
Materials and methods
Chemicals, enzymes, and nucleic acids
All chemicals were purchased from Bioshop Canada
Inc., Toronto, Canada. Restriction enzymes and oligode-
oxynucleotides were purchased from Gibco Products Inc.,
Mississauga, Ontario, Canada. Natural tRNALys3 was pur-
chased from Bio S&T, Montreal, Quebec, Canada. Het-
erodimeric HIV-1 wild-type RT and M184V mutated RT
were prepared and purified as described (Le Grice et al.,
1995).
Construction of RNA expression plasmids and in vitro
transcription of HIV-1 RNA
Construction of the in vitro wild-type HIV-1 RNA tem-
plate expression plasmid pHIV-PBS was carried out as
described previously (Arts et al., 1994). Expression plas-
mids containing the A-rich loop deletion or different rever-
sions were derived from PCR products of total cellular
DNA recovered from long-term culture MT-2 cells, trans-
fected with HIV-1 DNA containing the A-rich loop deletion
(HIV/A). After digestion with BglII and BssHII, the re-
sulting DNA fragments that contained either the A-rich loop
deletion or different reversion sequences were cloned into
pHIV-PBS and digested with the same enzymes to yield the
plasmids pPBS/A, pPBS/R0, pPBS/R12, pPBS/R1, and
pPBS/R2. To prepare RNA transcripts, plasmids were lin-
earized with BssHII and used as templates, using the
Megashortscript kit (Ambion, Austin, TX, USA) to generate
the HIV-1 RNA templates PBS/A, PBS/R0, PBS/R12,
PBS/R1, and PBS/R2. The RNA sequence of each template
is shown in Fig. 2.
In vitro reverse transcription initiation assays
A cell-free initiation assay was used to study the effect of
the A-rich loop and M184V mutated RT on the initiation of
synthesis of minus-strand strong stop DNA [()ssDNA].
Heat annealing can ensure the complete hybridization of
tRNA or DNA primer to an RNA template and was per-
formed in a 30-l reaction mixture containing 50 mM
Tris–HCl (pH 7.8), 50 mM NaCl, 20 nM natural or in vitro
synthesized tRNALys3 or DNA primer, and 40 nM template
PBS/WT and PBS/A. This mixture was incubated for 2
min at 95°C followed by 20 min at 70°C and 20 min at
37°C. After incubation for 5 min at 37°C in the presence of
6 mM MgCl2, 100 mM wild-type or M184V mutated RT
was added into the reaction mixture and incubated for an-
other 5 min at 37°C. Synthesis of ()ssDNA was initiated
by addition of a mixture of dNTPs to obtain final concen-
trations of 10 M for dGTP and dTTP and 1 M for dCTP.
ddATP 10 M was employed as a termination nucleotide
instead of dATP to give rise to a six-nucleotide initiation
product. [-32P]dCTP was used to trace the initiation pro-
cess. Aliquots of 2 l were removed at different time points,
and reactions were terminated in 8 l of a solution contain-
ing 80% formamide and 40 mM EDTA. Products were
separated on 8% polyacrylamide–7 M urea gels, which were
dried and exposed to Kodak film at 70°C. The results
were analyzed using Molecular Analysis software.
Synthesis of ()ssDNA using different RNA templates
Natural tRNA primers were hybridized onto the RNA
templates PBS/WT, PBS/A, PBS/R0, PBS/R12, PBS/R1,
and PBS/R2 by heat annealing. In vitro cell-free assay of
()ssDNA synthesis was carried out as described above.
After 100 mM wild-type HIV-1 RT was added into the
reaction mixture, synthesis of ()ssDNA was initiated by
addition of a mixture of dNTPs to obtain final concentra-
tions of 10 M for dATP, dGTP, dTTP and 1 M for dCTP.
The elongation products were radiolabeled by the incorpo-
ration of [-32P]dCTP.
Placement of the tRNALys3 primer onto the RNA template
by NCp7
The HIV-1 nucleocapsid protein (NCp7) used in this
study contains 72 amino acids and was generously provided
by Dr. Bernard Roques, Paris, France. A ratio of six nucle-
otides of template to one molecule of NCp7 was used to
obtain maximal annealing activity (Li et al., 1996). Natural
tRNALys3 at 40 nM, Various RNA templates at 200 nM, and
NCp7 at 9 M were incubated together in a buffer contain-
ing 50 mM Tris–HCl (pH 7.8), 50 mM NaCl, 5 mM MgCl2
and 10 mM dithiothreitol for 1 h at 37°C. Reverse transcrip-
tion was initiated under the same conditions as described
above. Aliquots of 10 l were removed at different times
and were treated with 200 g of proteinase K/ml at 37°C for
210 X. Wei et al. / Virology 311 (2003) 202–212
30 min and then extracted with phenol–chloroform. After
precipitation with a 4 volume of 95% ethanol, the prod-
ucts were separated on gels and visualized as described
above.
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